| 查看: 1176 | 回复: 3 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
hdang2003木虫 (著名写手)
|
[交流]
GSK中国的中药研究部门 转自丁香园 已有3人参与
|
||
|
Britain’s biggest drug maker last week unveiled the outcome of a review of its 38 groups of scientists, known as Discovery Performance Units (DPU), saying it would close three units and open four. The Sunday Telegraph can reveal the new units will look at traditional Chinese medicines, investigating how their principles can be applied to making new, synthetic, molecules. “Within our discovery organisation in China we have created a DPU that will marry traditional Chinese medicine with modern drug discovery and clinical efficacy,” said Moncef Slaoui, Glaxo’s chairman of research and development. “With modern technology we have the potential to yield new molecular entities with significant efficacy.” The new unit will be based in China – Glaxo launched an R&D centre in Shanghai almost five years ago. With its pharmaceutical market forecast to mushroom to more than $100bn (?63.5bn) by 2015, China is one of the most important battlegrounds for drug companies facing pricing pressure and more competition from generics. Glaxo’s move reflects a wish by drug companies to adapt their research to particular regions. Six years ago, AstraZeneca established a centre in China to study diseases prevalent in Asia, such as liver and stomach cancer, and lung conditions. Last October, Astra also said it planned to invest $200m in a new Chinese factory making intravenous and oral solid medicines. Astra’s sales in emerging markets, including China, grew 10pc to $5.8bn last year, while Glaxo’s Asia Pacific revenues grew 7pc to ?1.8bn. 个人认为中药的前途肯定是光明的，甚至好于西药，但在过去的上千年时间里，中药的发展步伐几近停滞，是不是中药的发展得改变思路？大型药企的介入将会是个好的开端。 |
回复此楼» 本帖已获得的红花（最新10朵）
1994yw» 猜你喜欢
211高校2026年入学博士名额
已经有16人回复
-
海勃原辅料助力银屑病一线外用制剂开发
已经有0人回复
-
药理学论文润色/翻译怎么收费?
已经有151人回复
-
二乙烯基砜的合成路径
已经有4人回复
-
求一株[b]敲除MTAP(human)的HCT-116(人结肠癌细胞)/b]细胞
已经有0人回复
-
这个自发加氧反应的机理是什么？
已经有7人回复
-
求助！求美国食品化学药典内容：FCC13【低聚果糖专论】
已经有0人回复
-
【2027博士申请】纳米药物递送方向
已经有5人回复
-
消耗微量API，便可预测早期研发阶段的HME工艺可行性
已经有0人回复
-
反应液中苯酐除去
已经有1人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 逆向恋爱术【转载】
已经有28人回复
- 中药缓释制剂研究现状
已经有8人回复
- 转化率接近100%的反应如何考察扩散对动力学的影响
已经有3人回复
- 中央民族少数民族医药研究院（985）和浙江中医药大学（普通二本），哪个更好
已经有8人回复
- 请教坐标与经纬度的转换
已经有1人回复
- 【转载】几个有道理的小故事，值得一看
已经有99人回复
- 【转帖】进口种子先免费后高价 我国种业该如何反思
已经有23人回复
4楼2012-02-21 18:03:40
1994yw
木虫 (正式写手)
- 应助: 8 (幼儿园)
- 金币: 1708.3
- 散金: 105
- 帖子: 646
- 在线: 79.5小时
- 虫号: 1242523
- 注册: 2011-03-23
- 专业: 药物设计与药物信息
2楼2012-02-21 15:19:43
weixiaogang
木虫 (正式写手)
- 应助: 24 (小学生)
- 金币: 3639.3
- 散金: 5
- 红花: 2
- 帖子: 711
- 在线: 193小时
- 虫号: 1470249
- 注册: 2011-11-01
- 性别: GG
- 专业: 药剂学
3楼2012-02-21 16:54:22
投票:
